10x Genomics adds Kim Popovits to its Board of Directors

– USA, CA –  10x Genomics, Inc. (Nasdaq: TXG) today announced the appointment of Kim Popovits, former Chairman of the Board, President and CEO of Genomic Health, Inc., to the Board of Directors. She brings decades of experience in scaling organizations, building global operations and advancing innovations in both the diagnostics and pharmaceutical industries.

“Kim has been a leader and a pioneer in introducing new technologies into the healthcare system impacting the lives of countless patients during her time at Genomic Health and Genentech,” said Serge Saxonov, co-founder and CEO of 10x Genomics. “Today, more than ever, we need to enable scientists to make discoveries that will lead to better patient outcomes, and we are excited to have Kim join the Board to accelerate our efforts.”

About Kim Popovits

Kim arrived at Genomic Health in 2002 as President and COO, before becoming CEO in 2009 and Chairman of the Board in 2012. Under her leadership, Genomic Health became the industry leader in genomic-based diagnostic tests that address both the overtreatment and optimal treatment of cancer, resulting in an acquisition by Exact Sciences (Nasdaq: EXAS) in November 2019.

Prior to joining Genomic Health, Kim held several management roles at Genentech, Inc. including Senior Vice President of Marketing and Sales where she led the commercialization of 14 new therapies in the biotechnology industry. Before Genentech, Kim was at American Critical Care, a Division of American Hospital Supply, a supplier of healthcare products to hospitals.

“I am excited to be joining a team that is leading the advancement of science at a pace that will transform clinical practice and lead to better outcomes for patients,” said Popovits. “The track record of the 10x team in delivering innovations to our industry is impressive and I look forward to applying my background towards enhancing the continued success of the company.”

In addition to her Board position at 10x Genomics, Kim is a current member of the Boards of Directors for Kiniksa Pharmaceuticals, Ltd. and MyoKardia, Inc., and previously served on the Board of ZS Pharma Inc.

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including 97 of the top 100 global research institutions and 19 of the top 20 global pharmaceutical companies, and have been cited in over 700 research papers on discoveries ranging from oncology to immunology and neuroscience. The company’s patent portfolio comprises more than 700 issued patents and patent applications.

For more information: https://www.10xgenomics.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team

here the original post =>